Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries

por Abulfathi, Ahmed A., Chaba, Linda A., Svensson, Elin M., Pillai, Goonaseelan C., Rosenkranz, Bernd
Publicado 2022

Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018

por du Toit, Tessa, Esterhuizen, Tonya M., Tiffin, Nicki, Abulfathi, Ahmed A., Reuter, Helmuth, Decloedt, Eric H.
Publicado 2020

New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians

por Aguilar Diaz, Jessica M, Abulfathi, Ahmed A, te Brake, Lindsey HM, van Ingen, Jakko, Kuipers, Saskia, Magis-Escurra, Cecile, Raaijmakers, Jelmer, Svensson, Elin M, Boeree, Martin J
Publicado 2023

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

por Abulfathi, Ahmed A., de Jager, Veronique, van Brakel, Elana, Reuter, Helmuth, Gupte, Nikhil, Vanker, Naadira, Barnes, Grace L., Nuermberger, Eric, Dorman, Susan E., Diacon, Andreas H., Dooley, Kelly E., Svensson, Elin M.
Publicado 2021

Drug concentration at the site of disease in children with pulmonary tuberculosis

por Lopez-Varela, Elisa, Abulfathi, Ahmed A., Strydom, Natasha, Goussard, Pierre, van Wyk, Abraham C., Demers, Anne Marie, Deventer, Anneen Van, Garcia-Prats, Anthony J., van der Merwe, Johannes, Zimmerman, Matthew, Carter, Claire L., Janson, Jacques, Morrison, Julie, Reuter, Helmuth, Decloedt, Eric H., Seddon, James A., Svensson, Elin M., Warren, Rob, Savic, Radojka M., Dartois, Véronique, Hesseling, Anneke C.
Publicado 2022